eISSN: 2354-0265
ISSN: 2353-6942
Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO
Current issue Archive Online first About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
2/2024
vol. 18
 
Share:
Share:
LETTERS TO THE EDITOR
Letter to the Editor

COMMUNITY PHARMACIST-PHYSICIAN COLLABORATION IN MANAGING POLYPHARMACY AND MULTIMORBIDITY IN POLAND AND PORTUGAL

Filipe Prazeres
1, 2

  1. Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal
  2. Family Health Unit Beira Ria, Gafanha da Nazaré, Portugal
Health Prob Civil. 2024; 18(2): 125-126
Online publish date: 2024/04/04
Article file
Get citation
 
PlumX metrics:
 

Dear Editor,

I read the article published in your journal Health Problems of Civilization in the first issue of 2024 titled “Physicians-in-training attitudes towards the community pharmacist-physician collaboration and pharmaceutical care: a 2022 cross-sectional survey in Poland” by Wrześniewska-Wal et al. [1] with an exceptional interest. The authors studied a sample of 509 doctors undergoing specialization training in Poland and concluded that although the collaboration between physicians and pharmacists is important it is still limited in the context of Poland’s healthcare system [1].

Pharmacist-physician collaboration is fundamental in managing the increasing burden of chronic diseases, which often contribute to polypharmacy (five or more medications) for treatment. Polypharmacy is a matter of serious concern since it is linked with negative health outcomes [2].

Like in Poland, the Portuguese healthcare system faces the burden of chronic diseases with a high frequency of multimorbidity (two or more chronic health problems) in more than 70% of adult patients in the primary care setting [3]. In Portugal, the cooperation of primary care physicians and pharmacists is also scarce. But in my opinion, they should be working closely together to ensure the safe and effective use of medications, minimize adverse drug reactions, and optimize therapeutic outcomes to reduce polypharmacy as it was recognized by the physicians-in-training in the study by Wrześniewska-Wal et al. [1], especially when managing patients with multimorbidity. This cooperation is also important in the physicians’ daily work with medication review, identifying potential drug interactions, and in transmitting pharmacological information and advice (e.g. emergency oral contraception counseling [4]). In Portugal, a previously published qualitative study showed that pharmacists were considered by the elderly patients as having the role of professional help to reach to discuss the deprescription process [5].

The study by Wrześniewska-Wal et al. [1] also revealed that physicians lack knowledge about pharmacists’ responsibilities in Poland, this can be a factor that could hamper the collaboration between physicians and pharmacists in addressing issues like polypharmacy in patients with multimorbidity and should be studied in other countries with the aging population, such as Portugal.

Enhancing education and collaboration training may facilitate a better relationship between physicians and pharmacists to improve patient outcomes, particularly in managing complex polypharmacy regimens commonly associated with multimorbidity. Nonetheless, further studies are still needed to determine the clear role of pharmaceutical care in this setting, as pointed out by the literature [2].

Notes

[1] Prazeres F. Community pharmacist-physician collaboration in managing polypharmacy and multimorbidity in Poland and Portugal. Health Prob Civil. 2024; 18(2): 125-126. https://doi.org/10.5114/hpc.2024.138538

References

1 

Wrześniewska-Wal I, Pinkas J, Jankowski M. Physicians-in-training attitudes towards the community pharmacist-physician collaboration and pharmaceutical care: a 2022 cross-sectional survey in Poland. Health Prob Civil. 2024; 18(1): 94-107. 10.5114/hpc.2023.133085

2 

Cole JA, Gonçalves-Bradley DC, Alqahtani M, Barry HE, Cadogan C, Rankin A, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2023; 10(10): CD008165. 10.1002/14651858.CD008165.pub5

3 

Prazeres F, Santiago L. Prevalence of multimorbidity in the adult population attending primary care in Portugal: a cross-sectional study. BMJ Open. 2015; 5: e009287. 10.1136/bmjopen-2015-009287

4 

Prazeres F. Letter to the Editor concerning “Knowledge and Patterns of Use of Emergency Oral Contraception among Portuguese Female Users of Healthcare Services”. Acta Med Port. 2022; 35(4): 305. 10.20344/amp.17998

5 

Simões P, Foreman N, Xavier B, Prazeres F, Maricoto T, Santiago L, et al. The elderly’s thoughts and attitudes about polypharmacy and deprescribing: a qualitative pilot study in Portugal. Societies. 2022; 12(6): 162. 10.3390/soc12060162

Copyright: © 2024 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.